Category Archives: Uncategorized

Gates Foundation Says New Efforts Needed to Bolster Pharmacovigilance Systems in Developing World.

Link | Posted on by | Leave a comment

Americas Health Authorities Meeting

On the 20th and 21st of February of 2014, representatives of the five Latin-American Health Authorities of Regional Reference recognized by the Pan American Health Organization, plus those of the FDA, Health Canada, and El Salvador’s regulatory agency met in … Continue reading

Posted in Argentina, Brazil, Canada, Colombia, Cuba, Mexico, Uncategorized, USA | Tagged , , , , , , , , , , , , , , , , , , , , , | 2 Comments

Recommended movie: Fight to Live (2012)

The documentary FIGHT TO LIVE follows the pursuit of emerging cures for terminal diseases as told through the stories of patients, patient advocates and the companies who stake their future on the discovery of new treatments. http://www.imdb.com/title/tt2084832/ It can be … Continue reading

Posted in Uncategorized | Leave a comment

http://www.pharmaphorum.com/articles/what-is-the-current-situation-in-the-pharma-markets-of-latin-america-interview-with-market-access-expert

Link | Posted on by | Leave a comment

Top 10 Pharma – products in the pipeline

Did you know that you can consult which new innovations are in the pipelines of the top 10 pharma companies directly from their websites? Have a look! 1- Johnson&Johnson 2- Pfizer 3- Novartis 4- Sanofi 5- Merck&Co 6- GlaxoSmithKline 7- Abbott … Continue reading

Posted in Uncategorized | Tagged , | 1 Comment

Puerto Rico to ‘opportunistically pursue’ biologics to regenerate industry.

Link | Posted on by | 1 Comment

Argentina: Site Master File now required by ANMAT for national sites

Starting on November 19th, 2o13, sites in Argentina approved by ANMAT to manufacture or package, in own or contract facility, or import or export, both drug products and APIs, have to submit their Site Master Files (SMF) annually. This is … Continue reading

Posted in Argentina, Uncategorized | Tagged , , , , , , , , , , , , , , | 2 Comments